Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, pathways, authors, ontology terms, etc. (e.g. eve, embryo, zen, allele)
  • Use OR to search for either of two terms (e.g. fly OR drosophila) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. dros* for partial matches or fly AND NOT embryo to exclude a term

Search results 4101 to 4200 out of 44733 for *

Category restricted to GOTerm (x)

<< First    < Previous  |  Next >    Last >>
0.018s

Categories

Category: GOTerm
« show all
Type Details Score
GO Term
GO:0002206 | gene conversion of immunoglobulin genes
Description: The somatic process in which immunoglobulin genes are diversified through the mechanism of gene conversion.
•
•
•
•
•
GO Term
GO:0002565 | somatic diversification of immune receptors via gene conversion
Description: The process in which immune receptor genes are diversified through gene conversion.
•
•
•
•
•
GO Term
GO:0002207 | gene conversion of immunoglobulin genes involved in immune response
Description: The somatic process in which immunoglobulin genes are diversified through the mechanism of gene conversion following the induction of and contributing to an immune response.
•
•
•
•
•
GO Term
GO:0002210 | behavioral response to wounding
Description: A behavioral response resulting from wounding.
•
•
•
•
•
GO Term
GO:0002213 | defense response to insect
Description: A response to protect an organism from a directly detected or perceived external threat from an insect or insects to that organism.
•
•
•
•
•
GO Term
GO:0002211 | behavioral defense response to insect
Description: A behavioral response seeking to protect an organism from an a perceived external threat from an insect or insects to that organism.
•
•
•
•
•
GO Term
GO:0002215 | defense response to nematode
Description: A response to protect an organism from a directly detected or perceived external threat from a nematode or nematodes, which results in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
•
•
•
•
•
GO Term
GO:0002212 | behavioral defense response to nematode
Description: A behavioral response seeking to protect an organism from an a perceived external threat from a nematode or nematodes to that organism.
•
•
•
•
•
GO Term
GO:0002220 | innate immune response activating cell surface receptor signaling pathway
Description: Any series of molecular signals leading to activation of the innate immune response generated as a consequence of binding to a cell surface receptor.
•
•
•
•
•
GO Term
GO:0002758 | innate immune response-activating signal transduction
Description: The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately leading to activation or perpetuation of an innate immune response.
•
•
•
•
•
GO Term
GO:0002222 | stimulatory killer cell immunoglobulin-like receptor signaling pathway
Description: Any series of molecular signals generated as a consequence of binding to a killer cell immunoglobulin-like receptor capable of cellular activation.
•
•
•
•
•
GO Term
GO:0002223 | stimulatory C-type lectin receptor signaling pathway
Description: Any series of molecular signals generated as a consequence of binding to a C-type lectin receptor capable of cellular activation.
•
•
•
•
•
GO Term
GO:0002784 | regulation of antimicrobial peptide production
Description: Any process that modulates the frequency, rate, or extent of antimicrobial peptide production.
•
•
•
•
•
GO Term
GO:0002225 | positive regulation of antimicrobial peptide production
Description: Any process that activates or increases the frequency, rate, or extent of antimicrobial peptide production.
•
•
•
•
•
GO Term
GO:0002702 | positive regulation of production of molecular mediator of immune response
Description: Any process that activates or increases the frequency, rate, or extent of the production of molecular mediator of immune response.
•
•
•
•
•
GO Term
GO:0002775 | antimicrobial peptide production
Description: The synthesis or release of an antimicrobial peptide during an immune response, resulting in an increase in intracellular or extracellular levels. Such peptides may have protective properties against bacteria, fungi, viruses, or protozoa.
•
•
•
•
•
GO Term
GO:0002760 | positive regulation of antimicrobial humoral response
Description: Any process that activates or increases the frequency, rate, or extent of an antimicrobial humoral response.
•
•
•
•
•
GO Term
GO:0002700 | regulation of production of molecular mediator of immune response
Description: Any process that modulates the frequency, rate, or extent of the production of molecular mediator of immune response.
•
•
•
•
•
GO Term
GO:0002759 | regulation of antimicrobial humoral response
Description: Any process that modulates the frequency, rate, or extent of an antimicrobial humoral response.
•
•
•
•
•
GO Term
GO:0002227 | innate immune response in mucosa
Description: Any process of the innate immune response that takes place in the mucosal tissues.
•
•
•
•
•
GO Term
GO:0002385 | mucosal immune response
Description: An immune response taking place in mucosal tissues, including those of the intestinal tract, nasal and upper respiratory tract, and genital tract.
•
•
•
•
•
GO Term
GO:0002251 | organ or tissue specific immune response
Description: An immune response taking place in an organ or tissues such as the liver, brain, mucosa, or nervous system tissues.
•
•
•
•
•
GO Term
GO:0002228 | natural killer cell mediated immunity
Description: The promotion of an immune response by natural killer cells through direct recognition of target cells or through the release of cytokines.
•
•
•
•
•
GO Term
GO:0002239 | response to oomycetes
Description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from an oomycetes.
•
•
•
•
•
GO Term
GO:0002229 | defense response to oomycetes
Description: Reactions triggered in response to the presence of oomycetes that act to protect the cell or organism.
•
•
•
•
•
GO Term
GO:0050691 | regulation of defense response to virus by host
Description: Any host process that modulates the frequency, rate, or extent of the antiviral response of a host cell or organism.
•
•
•
•
•
GO Term
GO:0002230 | positive regulation of defense response to virus by host
Description: Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication.
•
•
•
•
•
GO Term
GO:0002231 | detection of oomycetes
Description: The series of events in which a stimulus from an oomycetes is received and converted into a molecular signal.
•
•
•
•
•
GO Term
GO:0002523 | leukocyte migration involved in inflammatory response
Description: The movement of a leukocyte within or between different tissues and organs of the body contributing to an inflammatory response.
•
•
•
•
•
GO Term
GO:0002232 | leukocyte chemotaxis involved in inflammatory response
Description: The movement of an immune cell in response to an external stimulus contributing to an inflammatory response.
•
•
•
•
•
GO Term
GO:0002522 | leukocyte migration involved in immune response
Description: The movement of a leukocyte within or between different tissues and organs of the body as part of an immune response.
•
•
•
•
•
GO Term
GO:0002233 | leukocyte chemotaxis involved in immune response
Description: The movement of an immune cell in response to an external stimulus a part of an immune response.
•
•
•
•
•
GO Term
GO:0002234 | detection of endoplasmic reticulum overloading
Description: The series of events in which a stimulus generated by the accumulation of normal or misfolded proteins in the endoplasmic reticulum is received and converted into a molecular signal.
•
•
•
•
•
GO Term
GO:0006983 | ER overload response
Description: The series of molecular signals generated by the accumulation of normal or misfolded proteins in the endoplasmic reticulum and leading to activation of transcription by NF-kappaB.
•
•
•
•
•
GO Term
GO:0006984 | ER-nucleus signaling pathway
Description: Any series of molecular signals that conveys information from the endoplasmic reticulum to the nucleus, usually resulting in a change in transcriptional regulation.
•
•
•
•
•
GO Term
GO:0002235 | detection of unfolded protein
Description: The series of events in which an unfolded protein stimulus is received and converted into a molecular signal.
•
•
•
•
•
GO Term
GO:0002236 | detection of misfolded protein
Description: The series of events in which a misfolded protein stimulus is received and converted into a molecular signal.
•
•
•
•
•
GO Term
GO:0051788 | response to misfolded protein
Description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus.
•
•
•
•
•
GO Term
GO:0002238 | response to molecule of fungal origin
Description: Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of fungal origin such as chito-octamer oligosaccharide.
•
•
•
•
•
GO Term
GO:0002240 | response to molecule of oomycetes origin
Description: Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of oomycetes origin.
•
•
•
•
•
GO Term
GO:0009608 | response to symbiont
Description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a symbiont, an organism living with an organism of a different species in close physical association. The symbiont is defined as the smaller of the organisms involved in a symbiotic interaction.
•
•
•
•
•
GO Term
GO:0002241 | response to parasitic plant
Description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a parasitic plant.
•
•
•
•
•
GO Term
GO:0002242 | defense response to parasitic plant
Description: Reactions triggered in response to the presence of a parasitic plant that act to protect an organism.
•
•
•
•
•
GO Term
GO:0009602 | detection of symbiont
Description: The series of events in which a stimulus from a symbiont (an organism living in close physical association with an organism of a different species) is received and converted into a molecular signal. The symbiont is defined as the smaller of the organisms involved in a symbiotic interaction.
•
•
•
•
•
GO Term
GO:0002243 | detection of parasitic plant
Description: The series of events in which a stimulus from a parasitic plant is received and converted into a molecular signal.
•
•
•
•
•
GO Term
GO:0002246 | wound healing involved in inflammatory response
Description: The series of events that restore integrity to damaged tissue that contribute to an inflammatory response.
•
•
•
•
•
GO Term
GO:0090594 | inflammatory response to wounding
Description: The immediate defensive reaction by vertebrate tissue to injury caused by chemical or physical agents.
•
•
•
•
•
GO Term
GO:0002247 | clearance of damaged tissue involved in inflammatory response wound healing
Description: The series of events leading to removal of necrotic debris that contribute to an inflammatory response.
•
•
•
•
•
GO Term
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing
Description: The series of events leading to growth of connective tissue when loss of tissues that are incapable of regeneration occurs, or when fibrinous exudate cannot be adequately cleared that contribute to an inflammatory response.
•
•
•
•
•
GO Term
GO:0097709 | connective tissue replacement
Description: The series of events leading to growth of connective tissue when loss of tissues that are incapable of regeneration occurs, or when fibrinous exudate cannot be adequately cleared.
•
•
•
•
•
GO Term
GO:0002507 | tolerance induction
Description: A process that directly activates any of the steps required for tolerance, a physiologic state in which the immune system does not react destructively against the components of an organism that harbors it or against antigens that are introduced to it.
•
•
•
•
•
GO Term
GO:0002249 | lymphocyte anergy
Description: Any process contributing to lymphocyte anergy, a state of functional inactivation.
•
•
•
•
•
GO Term
GO:0002254 | kinin cascade
Description: A series of reactions that takes place outside the cell that occur as a result of by-products of tissue damage, including collagen, cartilage, and basement membrane. The ultimate product of the kinin cascade include kallidin and bradykinin, agents known to induce smooth muscle contraction, vasoconstriction, and increased vascular permeability.
•
•
•
•
•
GO Term
GO:0002255 | tissue kallikrein-kinin cascade
Description: A series of reactions that takes place outside the cell initiated by the action of tissue (glandular) kallikreins on low molecular weight kininogen in response to tissue damage. Tissue kallikreins are present in glandular tissues and their fluids, such as the salivary glands, sweat glands, pancreas, and kidney. The ultimate products of the tissue kallikrein-kinin cascade include kallidin and bradykinin, agents known to induce smooth muscle contraction, vasoconstriction, and increased vascular permeability.
•
•
•
•
•
GO Term
GO:0002256 | regulation of kinin cascade
Description: Any process that modulates the frequency, rate, or extent of the kinin cascade.
•
•
•
•
•
GO Term
GO:2000257 | regulation of protein activation cascade
Description: Any process that modulates the frequency, rate or extent of protein activation cascade.
•
•
•
•
•
GO Term
GO:0002257 | negative regulation of kinin cascade
Description: Any process that stops, prevents, or reduces the frequency, rate, or extent of the kinin cascade.
•
•
•
•
•
GO Term
GO:2000258 | negative regulation of protein activation cascade
Description: Any process that stops, prevents or reduces the frequency, rate or extent of protein activation cascade.
•
•
•
•
•
GO Term
GO:0002258 | positive regulation of kinin cascade
Description: Any process that activates or increases the frequency, rate, or extent of the kinin cascade.
•
•
•
•
•
GO Term
GO:2000259 | positive regulation of protein activation cascade
Description: Any process that activates or increases the frequency, rate or extent of protein activation cascade.
•
•
•
•
•
GO Term
GO:0002264 | endothelial cell activation involved in immune response
Description: A change in the morphology or behavior of an endothelial cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002259 | endothelial cell activation within high endothelial venule involved in immune response
Description: A change in the morphology or behavior of an endothelial cell within a high endothelial venule resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0042118 | endothelial cell activation
Description: The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
•
•
•
•
•
GO Term
GO:0002261 | mucosal lymphocyte homeostasis
Description: The process of regulating the proliferation and elimination of lymphocytes such that the total number of lymphocytes within the mucosal tissue of an organism is stable over time in the absence of an outside stimulus.
•
•
•
•
•
GO Term
GO:0048143 | astrocyte activation
Description: A change in morphology and behavior of an astrocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
•
•
•
•
•
GO Term
GO:0002265 | astrocyte activation involved in immune response
Description: A change in the morphology or behavior of an astrocyte resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0014002 | astrocyte development
Description: The process aimed at the progression of an astrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
•
•
•
•
•
GO Term
GO:0048708 | astrocyte differentiation
Description: The process in which a relatively unspecialized cell acquires the specialized features of an astrocyte. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
•
•
•
•
•
GO Term
GO:0021782 | glial cell development
Description: The process aimed at the progression of a glial cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
•
•
•
•
•
GO Term
GO:0002266 | follicular dendritic cell activation
Description: A change in the morphology or behavior of a follicular dendritic cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
•
•
•
•
•
GO Term
GO:0002267 | follicular dendritic cell activation involved in immune response
Description: A change in the morphology or behavior of a follicular dendritic cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002268 | follicular dendritic cell differentiation
Description: The process in which a relatively unspecialized precursor cell acquires the specialized features of a follicular dendritic cell.
•
•
•
•
•
GO Term
GO:0002270 | plasmacytoid dendritic cell activation
Description: A change in the morphology or behavior of a plasmacytoid dendritic cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
•
•
•
•
•
GO Term
GO:0002271 | plasmacytoid dendritic cell activation involved in immune response
Description: A change in the morphology or behavior of a plasmacytoid dendritic cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002272 | plasmacytoid dendritic cell differentiation involved in immune response
Description: The process in which an immature plasmacytoid dendritic cell acquires the specialized features of a mature plasmacytoid dendritic cell contributing to an immune response.
•
•
•
•
•
GO Term
GO:0002273 | plasmacytoid dendritic cell differentiation
Description: The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a plasmacytoid dendritic cell.
•
•
•
•
•
GO Term
GO:0097028 | dendritic cell differentiation
Description: The process in which a precursor cell type acquires the specialized features of a dendritic cell. A dendritic cell is a leukocyte of dendritic lineage specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation.
•
•
•
•
•
GO Term
GO:0002275 | myeloid cell activation involved in immune response
Description: A change in the morphology or behavior of a myeloid cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002276 | basophil activation involved in immune response
Description: A change in morphology and behavior of a basophil resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the basophil has specifically bound via IgE bound to Fc-epsilonRI receptors, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0045575 | basophil activation
Description: The change in morphology and behavior of a basophil resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the basophil has specifically bound via IgE bound to Fc-epsilonRI receptors.
•
•
•
•
•
GO Term
GO:0036230 | granulocyte activation
Description: The change in morphology and behavior of a granulocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
•
•
•
•
•
GO Term
GO:0002277 | myeloid dendritic cell activation involved in immune response
Description: The change in morphology and behavior of a myeloid dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002278 | eosinophil activation involved in immune response
Description: The change in morphology and behavior of a eosinophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0043307 | eosinophil activation
Description: The change in morphology and behavior of a eosinophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
•
•
•
•
•
GO Term
GO:0045576 | mast cell activation
Description: The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.
•
•
•
•
•
GO Term
GO:0002279 | mast cell activation involved in immune response
Description: The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0042117 | monocyte activation
Description: The change in morphology and behavior of a monocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
•
•
•
•
•
GO Term
GO:0002280 | monocyte activation involved in immune response
Description: The change in morphology and behavior of a monocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002281 | macrophage activation involved in immune response
Description: A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002282 | microglial cell activation involved in immune response
Description: The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0042119 | neutrophil activation
Description: The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
•
•
•
•
•
GO Term
GO:0002283 | neutrophil activation involved in immune response
Description: The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002284 | myeloid dendritic cell differentiation involved in immune response
Description: The process in which an immature myeloid dendritic cell acquires the specialized features of a mature myeloid dendritic cell as part of an immune response.
•
•
•
•
•
GO Term
GO:0043011 | myeloid dendritic cell differentiation
Description: The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
•
•
•
•
•
GO Term
GO:0002573 | myeloid leukocyte differentiation
Description: The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte lineage.
•
•
•
•
•
GO Term
GO:0002287 | alpha-beta T cell activation involved in immune response
Description: The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002288 | NK T cell activation involved in immune response
Description: The change in morphology and behavior of a mature or immature natural killer T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
GO Term
GO:0002289 | NK T cell proliferation involved in immune response
Description: The expansion of a NK T cell population by cell division as part of an immune response.
•
•
•
•
•
GO Term
GO:0002310 | alpha-beta T cell proliferation involved in immune response
Description: The expansion of an alpha-beta T cell population by cell division as part of an immune response.
•
•
•
•
•
GO Term
GO:0002290 | gamma-delta T cell activation involved in immune response
Description: The change in morphology and behavior of a gamma-delta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.
•
•
•
•
•
USDA
InterMine logo
The Legume Information System (LIS) is a research project of the USDA-ARS:Corn Insects and Crop Genetics Research in Ames, IA.
LegumeMine || ArachisMine | CicerMine | GlycineMine | LensMine | LupinusMine | PhaseolusMine | VignaMine | MedicagoMine
InterMine © 2002 - 2022 Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, United Kingdom